120 related articles for article (PubMed ID: 28694401)
1. Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: A case report.
Küçük M; Öncel CR; Uçar M; Yıldırım AB
Turk Kardiyol Dern Ars; 2017 Jul; 45(5):458-461. PubMed ID: 28694401
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in patients with neurofibromatosis type I.
Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
[TBL] [Abstract][Full Text] [Related]
3. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
Stewart DR; Cogan JD; Kramer MR; Miller WT; Christiansen LE; Pauciulo MW; Messiaen LM; Tu GS; Thompson WH; Pyeritz RE; Ryu JH; Nichols WC; Kodama M; Meyrick BO; Ross DJ
Chest; 2007 Sep; 132(3):798-808. PubMed ID: 17573495
[TBL] [Abstract][Full Text] [Related]
4. Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis.
Giannakoulas G; Savvoulidis P; Grosomanidis V; Mouratoglou SA; Karvounis H; Hadjimiltiades S
BMC Pulm Med; 2016 Dec; 16(1):175. PubMed ID: 27927206
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
[No Abstract] [Full Text] [Related]
6. Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report.
Simeoni S; Puccetti A; Chilosi M; Tinazzi E; Prati D; Corrocher R; Lunardi C
J Med Invest; 2007 Aug; 54(3-4):354-8. PubMed ID: 17878687
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis-associated pulmonary hypertension: an ominous duo.
Coelho SG; Loureiro MJ
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32665279
[TBL] [Abstract][Full Text] [Related]
8. [Severe pulmonary involvement in the course of type 1 neurofibromatosis].
Martignac B; Gagnadoux F; Trzepizur W; Beneton N; Vinchon F; Paris A; Montani D; Goupil F
Rev Mal Respir; 2014 Sep; 31(7):621-3. PubMed ID: 25239584
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension associated with neurofibromatosis type 1.
Jutant EM; Girerd B; Jaïs X; Savale L; O'Connell C; Perros F; Sitbon O; Humbert M; Montani D
Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30158278
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension: a fatal complication of neurofibromatosis type 1.
Gumbiene L; Petrulioniene Z; Rucinskas K; Maneikiene V; Serpytis P; Dranenkiene A; Laucevicius A
Respir Care; 2011 Nov; 56(11):1844-8. PubMed ID: 21605478
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension and interstitial fibrosis in von Recklinghausen neurofibromatosis.
Porterfield JK; Pyeritz RE; Traill TA
Am J Med Genet; 1986 Nov; 25(3):531-5. PubMed ID: 3098100
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension and von Recklinghausen's disease: association and therapeutic difficulties.
Ennibi K; El Kassimi I; Asfalou I; Chaari J; Benyass A
Pneumologia; 2015; 64(3):55-7. PubMed ID: 26738373
[TBL] [Abstract][Full Text] [Related]
13. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary sarcoma complicated with neurofibromatosis type 1 (NF1).
Abe Y; Hatanaka H; Kamiya T; Yamazaki H; Kijima H; Inoue H; Ueyama Y; Nakamura M
Anticancer Res; 2003; 23(1B):613-6. PubMed ID: 12680156
[TBL] [Abstract][Full Text] [Related]
15. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
Side L; Taylor B; Cayouette M; Conner E; Thompson P; Luce M; Shannon K
N Engl J Med; 1997 Jun; 336(24):1713-20. PubMed ID: 9180088
[TBL] [Abstract][Full Text] [Related]
16. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
[TBL] [Abstract][Full Text] [Related]
17. A 63-Year-Old Woman With Neurofibromatosis Type 1 and Pulmonary Hypertension With Worsening Hypoxemia.
Chaddha U; Puscas I; Prosper A; Ganesh S; Yaghmour B
Chest; 2017 Oct; 152(4):e89-e93. PubMed ID: 28991555
[TBL] [Abstract][Full Text] [Related]
18. A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.
Güran S; Safali M
Cancer Genet Cytogenet; 2005 Jan; 156(1):86-8. PubMed ID: 15588864
[TBL] [Abstract][Full Text] [Related]
19. Glomus tumors in individuals with neurofibromatosis type 1.
Kumar MG; Emnett RJ; Bayliss SJ; Gutmann DH
J Am Acad Dermatol; 2014 Jul; 71(1):44-8. PubMed ID: 24685357
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension in neurofibromatosis.
Engel PJ; Baughman RP; Menon SG; Kereiakes DJ; Taylor L; Scott M
Am J Cardiol; 2007 Apr; 99(8):1177-8. PubMed ID: 17437753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
